Quantitative and qualitative determination of estrogen sulfates in human urine by liquid chromatography/tandem mass spectrometry using 96-well technology
Hw. Zhang et J. Henion, Quantitative and qualitative determination of estrogen sulfates in human urine by liquid chromatography/tandem mass spectrometry using 96-well technology, ANALYT CHEM, 71(18), 1999, pp. 3955-3964
A sensitive and robust method to determine five estrogen sulfates in human
urine has been developed employing high-throughput solid-phase extraction w
ith 96-well technology, and HPLC coupled with negative turbo ion spray tand
em mass spectrometry in the selected reaction monitoring mode. The five est
rogen sulfates determined include three major endogenous estrogen sulfates
in the human, estrone 3-sulfate (E-1-3S), estriol 3-sulfate (E-3-3S), and 1
7 beta-estradiol 3-sulfate (E-2-3S), and two biochemical synthetic estrogen
sulfates, 17 beta-estradiol 17-sulfate (E-2-17S) and 17 beta-estradiol 3,1
7-disulfate (E-2-3,17S), For E-2-3,17S, E-3-3S, and E-2-17S, external stand
ard calibration was used for quantitation, and for the remaining two compou
nds, internal standard calibration using a stable isotopic labeled internal
standard was employed. A total of 96 samples may be prepared with 96-well
C18 extraction disk plate techniques performed by a robot within 25 min inc
luding the time for evaporation of solvent. The lower level of quantitation
(LOQ) for these estrogen sulfates in human urine was determined at 0.2 ng/
mL based on 100-mu L aliquots of human urine using the optimum tuning param
eters for each individual selected precursor ion/product ion transition. Th
e assay was validated with a linear concentration range of 0.2-200 ng/mL, a
nd the interassay accuracy, intraassay precision, and interassay precision
do not exceed 8.6%, 12%, and 12%, respectively, by analysis of quality cont
rol samples at five concentration levels including the LOQ of 0.2 ng/mL, fr
om four 96-well plates. The target endogenous test articles were qualitativ
ely determined by comparing the full-scan LC/MS/MS mass spectra and retenti
on time in test samples and reference standards. The LOQ is significantly i
mproved compared to previous reports for the targeted compounds using LC/MS
/MS, The described simple and automated sample preparation procedure recove
red 91% of the target compounds. A total of 192 samples can be analyzed wit
hin 1 day(22 h), The method can measure the endogenous estrogen sulfates in
urine from both gravid and nongravid subjects.